查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497759

全球癌症疼痛治疗市场：按药物类型、给药途径、应用和最终用途 - 预测（2024-2030）

Cancer Pain Management Market by Drug Type (Nerve Blockers, Non-Opioids, Opioids), Route of Administration (Oral, Parental), Application, End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球癌痛治疗市场规模将达74.2亿美元，2024年将达78.6亿美元，复合年增长率为6.09%，2030年将达112.3亿美元。

癌症疼痛管理是指用于缓解与癌症及其治疗相关的疼痛的技术和程序。这种多学科方法是根据患者需求量身定制的，涵盖多种方法来改善癌症患者的生活品质。用于控制癌症相关疼痛的策略包括药物治疗（例如止痛药和鸦片类药物）和非药物介入（例如物理治疗、心理支持和补充疗法）。癌症疼痛的有效管理至关重要，因为它直接影响患者的舒适度、功能和整体健康。癌症发病率上升、人口老化、技术进步、监管效率和患者意识的提高正在推动癌症疼痛管理的需求。然而，阿片类药物危机、副作用、系统性医疗保健差异、成本障碍以及缺乏全面的疼痛管理知识所带来的挑战可能会阻碍市场成长。然而，该领域的新机会在于精准药物输送技术、非阿片类药物治疗的更多采用、综合数位健康工具以及补充和替代疗法的潜力。创新和业务扩张是透过探索非成瘾性镇痛药、增强的药物输送机制、药物遗传学和策略联盟来推动的。

主要市场统计
基准年[2023] 74.2亿美元
预测年份 [2024] 78.6亿美元
预测年份 [2030] 112.3亿美元
复合年增长率（%） 6.09%

区域洞察

以病人为中心的护理模式和对全面疼痛管理的重视正在美洲创建先进的癌症疼痛管理框架。高医疗保健支出和广泛的保险覆盖范围使得疼痛管理解决方案得到广泛采用。当地医疗保健系统为癌症患者提供大力支持，包括疼痛管理作为护理的基本方面。由于医疗保健系统不同和国家政策差异，欧盟 (EU) 国家在癌症疼痛管理方法上表现出很大差异。中东和非洲的经济资源存在显着的异质性，这直接影响癌痛治疗的可用性和品质。亚太地区快速扩张的医疗保健系统已经适应了癌症和相关疼痛日益流行的趋势。对医疗保健基础设施和医生培训计划的投资是明显的回应。强调适当疼痛控制和居家医疗的新政策正在扩大亚太地区癌症疼痛管理解决方案的范围。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在癌症疼痛管理市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对癌症疼痛管理市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在癌症疼痛管理市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地慢性疼痛和文明病的盛行率正在上升
      • 老年人口不断增长以及减轻疼痛的治疗方法需求
    • 抑制因素
      • 与产品召回相关的问题
    • 机会
      • 持续的产品开发活动和 FDA 对新产品的核准增加
      • 政府资助支持癌症疼痛管理
    • 任务
      • 与癌症疼痛治疗药物相关的副作用
  • 市场区隔分析
    • 药物类型：扩大鸦片类药物在癌症疼痛治疗的范围
    • 给药途径：口服药物越来越多地用于癌症疼痛治疗
    • 应用：乳癌癌痛管理解决方案的普及
    • 最终用途：医院中癌症止痛药的使用增加
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章癌痛治疗市场：依药物类型

  • 阻断剂
  • 非阿片类药物
  • 阿片类药物

第七章癌症疼痛治疗市场：依途径

  • 口服
  • 口服

第八章癌痛治疗市场：依应用分类

  • 血癌
  • 乳癌
  • 大肠直肠癌
  • 肺癌
  • 摄护腺癌

第九章癌痛治疗市场：依最终用途分类

  • 居家护理
  • 医院
  • 专科诊所

第10章美洲癌痛治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区癌症疼痛治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的癌症疼痛治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FDA核准非鸦片类止痛药用于治疗轻度至中度疼痛
    • Nevro (NVRO) 最新发布客製化慢性疼痛治疗
    • 伊史蒂夫和美敦力合作满足癌症疼痛患者的需求
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-144C638C8F7B

[197 Pages Report] The Cancer Pain Management Market size was estimated at USD 7.42 billion in 2023 and expected to reach USD 7.86 billion in 2024, at a CAGR 6.09% to reach USD 11.23 billion by 2030.

Cancer pain management refers to the practices and procedures employed in alleviating pain associated with cancer and its treatment. This multidisciplinary approach is tailored to the patient's needs and encompasses various methods to improve the quality of life for those with cancer. The strategies used for managing cancer-related pain may include pharmacological treatments, such as analgesics and opioids, and non-pharmacological interventions, such as physical therapy, psychological support, and complementary therapies. Effective management of cancer pain is pivotal because it directly impacts a patient's comfort, functioning, and overall well-being. The rising prevalence of cancer, an aging demographic, technological advancements, regulatory efficiencies, and heightened patient awareness have improved the need for cancer pain management. However, issues arising from the opioid crisis, adverse drug reactions, systemic healthcare disparities, cost barriers, and a lack of comprehensive pain management knowledge may impede market growth. Nevertheless, emerging opportunities within this domain lie in precision drug delivery technologies, increased non-opioid treatment adoption, integrated digital health tools, and the potential of complementary and alternative therapies. Innovation and business expansion are being driven by research into non-addictive analgesics, enhancement of drug delivery mechanisms, pharmacogenetics, and strategic collaborations.

KEY MARKET STATISTICS
Base Year [2023] USD 7.42 billion
Estimated Year [2024] USD 7.86 billion
Forecast Year [2030] USD 11.23 billion
CAGR (%) 6.09%

Regional Insights

Patient-centric care models and an emphasis on comprehensive pain management have led to an advanced cancer pain management framework in the Americas. High healthcare expenditure, coupled with extensive insurance coverage, allows for significant adoption of pain management solutions. The regional healthcare system provides substantial support for cancer patients, which includes pain management as a fundamental aspect of care. European Union countries exhibit high variability in cancer pain management approaches due to diverse healthcare systems and differing national policies. The Middle East and African region is characterized by significant heterogeneity in economic resources, which directly impacts the availability and quality of cancer pain management. The rapidly expanding healthcare system in the Asia-Pacific region has been adapting to the growing prevalence of cancer and its associated pain. Investment in healthcare infrastructure and physician training programs are evident response measures. New policies emphasizing adequate pain control and home-based care have broadened the scope of cancer pain management solutions in Asia-Pacific.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Cancer Pain Management Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising prevalence of chronic pain and lifestyle disorders worldwide
      • Increasing geriatric population and need for pain-reducing therapies
    • Market Restraints
      • Issues associated with product recalls
    • Market Opportunities
      • Ongoing product development activities and rising FDA approvals of new products
      • Government funding supporting cancer pain treatments
    • Market Challenges
      • Adverse effects associated with cancer pain management drugs
  • Market Segmentation Analysis
    • Drug Type: Growing applicability of opioids to treat cancer pain
    • Route of Administration: Growing availability of oral medications for cancer pain management
    • Application: Emerging penetration of cancer pain management solutions for breast cancer
    • End-Use: Elevating usage of cancer pain drugs in hospitals
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cancer Pain Management Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cancer Pain Management Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

FDA Approves Non-Opioid Painkiller for Mild-to-Moderate Pain

The U.S. Food and Drug Administration (FDA) has given its approval to a new non-opioid medication designed to alleviate mild to moderate pain in cancer patients. This development promises to offer relief without the associated risks of opioid use, such as addiction and overdose. The novel analgesic is poised to become a pivotal component in the pain management regimen, providing a safer alternative for patients and healthcare professionals aiming to mitigate the discomfort caused by cancer while curbing the potential for opioid dependence. [Published On: 2023-10-20]

Nevro's (NVRO) Latest Launch to Customize Chronic Pain Treatment

Nevro Corp. announced the introduction of its innovative HFX for PDN solution, signifying a strategic step to tailor its proprietary Senza system to the needs of patients suffering from painful Diabetic Peripheral Neuropathy (PDN). This launch showcases Nevro's commitment to expanding its high-frequency spinal cord stimulation technology for various indications and marks an important milestone in offering more personalized pain treatment options. [Published On: 2023-08-15]

Esteve and Medtronic are Collaborating to Address Cancer Pain Patients' Needs

Esteve, a pharmaceutical company, announced its collaboration with Medtronic, a global pioneer in medical technology, to meet the complex demands of cancer pain patients. This synergistic partnership is focused on delivering innovative solutions to enhance the quality of life for individuals affected by cancer-related pain. Esteve's expertise in pharmaceuticals and Medtronic's advanced medical technology are poised to bring forward a new era in pain management. [Published On: 2022-11-23]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cancer Pain Management Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cancer Pain Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Aegis Therapeutics, LLC, Aptinyx Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Baxter International Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Glaxosmithkline PLC, Grunenthal Group, Johnson & Johnson Services, Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Scilex Pharmaceuticals, Teva Pharmaceutical Industries Ltd., and Trevena Inc..

Market Segmentation & Coverage

This research report categorizes the Cancer Pain Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Type
    • Nerve Blockers
    • Non-Opioids
      • Acetaminophen
      • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Opioids
      • Fentanyl
      • Morphine
  • Route of Administration
    • Oral
    • Parental
  • Application
    • Blood Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Prostate Cancer
  • End-Use
    • Home care
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic pain and lifestyle disorders worldwide
      • 5.1.1.2. Increasing geriatric population and need for pain-reducing therapies
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing product development activities and rising FDA approvals of new products
      • 5.1.3.2. Government funding supporting cancer pain treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects associated with cancer pain management drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Type: Growing applicability of opioids to treat cancer pain
    • 5.2.2. Route of Administration: Growing availability of oral medications for cancer pain management
    • 5.2.3. Application: Emerging penetration of cancer pain management solutions for breast cancer
    • 5.2.4. End-Use: Elevating usage of cancer pain drugs in hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cancer Pain Management Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Nerve Blockers
  • 6.3. Non-Opioids
  • 6.4. Opioids

7. Cancer Pain Management Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Parental

8. Cancer Pain Management Market, by Application

  • 8.1. Introduction
  • 8.2. Blood Cancer
  • 8.3. Breast Cancer
  • 8.4. Colorectal Cancer
  • 8.5. Lung Cancer
  • 8.6. Prostate Cancer

9. Cancer Pain Management Market, by End-Use

  • 9.1. Introduction
  • 9.2. Home care
  • 9.3. Hospitals
  • 9.4. Specialty Clinics

10. Americas Cancer Pain Management Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cancer Pain Management Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cancer Pain Management Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA Approves Non-Opioid Painkiller for Mild-to-Moderate Pain
    • 13.3.2. Nevro's (NVRO) Latest Launch to Customize Chronic Pain Treatment
    • 13.3.3. Esteve and Medtronic are Collaborating to Address Cancer Pain Patients' Needs
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CANCER PAIN MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CANCER PAIN MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CANCER PAIN MANAGEMENT MARKET DYNAMICS
  • FIGURE 7. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CANCER PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CANCER PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANCER PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NERVE BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NERVE BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY FENTANYL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY FENTANYL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY MORPHINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY MORPHINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BLOOD CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 301. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 304. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 305. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 306. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 313. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 316. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 317. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 318. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 325. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 328. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY NON-OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 329. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2023 (USD MILLION)
  • TABLE 330. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 337. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG TYPE, 2018-20